Mandibular Advancement Device Therapy for Obstructive Sleep Apnea in Public Oral Health Services

Background: Obstructive sleep apnea (OSA) is a common disorder worldwide and its prevalence is growing in tandem with increased overweight and obesity. Untreated OSA increments the risk of cardiovascular disease, motor vehicle accidents, and even mortality. This is why undiagnosed OSA patients should be detected. Risk factors for OSA are overweight, male gender, age, and retrognathia. Common daytime symptoms of OSA are daytime sleepiness and morning headaches. Nighttime symptoms are restless sleep, numerous apneas that last over 10 seconds, snoring, sweating, and increased need for urination. OSA is divided into three levels of severity; mild (AHI 5-15/h) moderate (AHI 16-30), and severe (AHI